ACT's Top Scientist Sells $1.5 Million in Company Stock
The mainstream media waxed enthusiastic last month when a California hESC clinical trial reported positive results dealing with blindness.
The report was first published account of a human trial of embryonic stem cell based therapy and involved Advanced Cell Technology, which is headquartered in Santa Monica, Ca. Despite a glowing reception of the trial'…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.